Back to News
PartnershipDecember 10, 2025
HealthTech Nexus Partners with Leading Singapore Biomedical Research Institute
Partnership will pilot the Bio R&D data platform for translational research, covering clinical data management and AI-assisted drug target identification.
HealthTech Nexus has entered into a strategic partnership with a leading Singapore biomedical research institute to pilot the Bio R&D platform in a translational research setting. The collaboration will focus on unified clinical data management, AI-assisted target identification, and regulatory-ready data outputs.
🤝Partnership|December 10, 2025
More News Related Articles
📣Company NewsMarch 5, 2026
HealthTech Nexus Closes Seed Round to Accelerate AI Platform Development
Funding will be deployed to expand Bio R&D and RegIntel platform capabilities, with a focus on expanding into China, Japan, and Southeast Asian markets.
🚀Product LaunchJanuary 15, 2026
RegIntel Platform Goes Live with Multi-Country Regulatory Filing Support
The RegIntel platform provides real-time regulatory intelligence for pharma companies navigating NMPA, PMDA, and HSA filings.